Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China · Delayed Price · Currency is CNY 33.93
+0.12 (0.35%)
At close: Oct 28, 2025
SHA:688139 Market Cap
SHA:688139 has a market cap or net worth of 10.64 billion as of October 28, 2025. Its market cap has increased by 33.01% in one year.
Market Cap
10.64B
Enterprise Value
9.48B
Revenue
2.26B
Ranking
n/a
PE Ratio
39.09
Stock Price
33.93
Market Cap Chart
Since October 25, 2019, SHA:688139's market cap has increased from 9.66B to 10.64B, an increase of 10.18%. That is a compound annual growth rate of 1.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 10.59B | -4.72% |
| Dec 20, 2024 | 11.11B | -13.35% |
| Dec 29, 2023 | 12.82B | -36.13% |
| Dec 30, 2022 | 20.08B | -30.28% |
| Dec 31, 2021 | 28.80B | 39.10% |
| Dec 31, 2020 | 20.70B | 126.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 435.31B |
| WuXi AppTec | 306.38B |
| Shenzhen Mindray Bio-Medical Electronics | 267.94B |
| Sichuan Biokin Pharmaceutical | 145.45B |
| Shanghai United Imaging Healthcare | 116.57B |
| Aier Eye Hospital Group | 113.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.03B |
| Yunnan Baiyao Group Co.,Ltd | 100.56B |